Vivani (VANI) Enterprise Value to EBITDA Ratio
Vivani Medical, Inc. (VANI) relies on patent protection and the complexities of FDA certification, which effectively bars smaller players from the market. The company's US laboratories are developing extended-release drug delivery systems to combat obesity and diabetes. The confirmed price history on the chart shows that the EV/EBITDA dynamic is currently at 0.00. A stable research regime and the humanitarian status of its developments minimize external risks, ensuring sustainable business growth.
Comprehensive metric breakdowns and analytics for vivani.com (VANI)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
VANI - Net Financial Result|Projected Future Earnings Vivani Medical, Inc.|VANI - Price to Earnings Ratio|Forward P/E Multiple Vivani Medical|VANI - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization VANI|VANI - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Vivani Medical|VANI - Earnings per share for the trailing year|Quarterly EPS earnings growth vivani.com|VANI - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Vivani Medical, Inc.
- revenue and sales details:
Analysis of all company metrics:Vivani VANI
The implementation of ESG standards and energy-efficient factories at Vivani Medical (VANI) requires significant capital expenditures, making the tracking of debt load critically important. This indicator compares the total enterprise value (EV) with earnings before interest, taxes, depreciation, and amortization (EBITDA), allowing investors to assess the real value of assets inclusive of debt, which the historical EV/EBITDA dynamics of the company clearly reflect.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD (ReWalk Robotics Ltd.) - Enterprise Value to EBITDA Ratio|AMIX (Autonomix Medical) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IVF (INVO Fertility) - EV/EBITDA Multiple|Bone Biologics Corp. (BBLG) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BIOL (Biolase Inc.)|EV/EBITDA Multiple DYNT (Dynatronics)|EV/EBITDA Multiple Paragon 28 Inc. FNA|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
